House Appropriators' Report Tracks With FDA Concern About CBD Supplements

House Appropriators expect FDA to assert commitment to identifying lawful regulatory pathways for CBD food and supplements if those pathways are consistent with protection of public health. Committee also expresses concern over proliferation of CBD supplements and foods in violation of FDA regulations.

FDA words adn building icon

The US House Appropriations Committee's report with its fiscal year 2020 spending bill for the Food and Drug Administration states concern over the proliferation of foods and dietary supplements containing cannabidiols in violation of federal regulations.

The FY 2020 "Agriculture, Rural Development, Food and Drug Administration and Related Agencies” appropriation bill, passed along party lines...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation